Dublin, March 10, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Sample Type; By Product & Service Type; By Test Type; By Mode; By End Use; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
The global COVID-19 diagnostics market size is expected to reach USD 23.67 billion by 2027, according to the study.
The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
COVID-19 medical tests play an important role in management of coronavirus and thus helping in containing the virus infection. These tests are available as POC and non-POC across various healthcare settings such as hospitals, diagnostic centers, physician clinics, and research laboratories. POC test are comparatively easier than the other swab-based tests but they lack sensitivity and specificity thus providing a non-conclusive result.
While these tests are useful in real-time monitoring of infection as a preliminary test, the swab-based tests are necessity for confirmation of COVID-19 infection as they incorporate RT-PCR technology, which provide accurate results. The recent requirements for COVID-19 tests are higher accuracy, faster results, low-cost, and high sensitivity towards coronavirus.
The market drivers for COVID-19 diagnostic includes rapidly increasing COVID-19 infections across the globe, increasing number of patients undergoing diagnosis, government initiatives such as Sero testing, increased preference of physicians and patients towards POC testing, and increased requirement for COVID-19 test by non-profit organizations.
Companies such as Cepheid, 1drop Inc., ALDATU BIOSCIENCES, Altona Diagnostics GmbH, Perkin Elmer, Inc., bioMerieux SA, Danaher, Hologic Inc., Abbott, Luminex Corporation, ADT Biotech, Mylab Discovery Solutions Pvt Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics, Quidel, Neuberg Diagnostics, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd. and Veredus Laboratories are some of the key players operating in the market.
The analyst has segmented the Covid-19 diagnostics market report on the basis of product & service, sample type, test type, mode, & end-use
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. COVID-19 Diagnostics Market Insights
5. COVID-19 Diagnostics Market Assessment by Product & Service
6. Global COVID-19 Diagnostics Market, by Sample Type
7. Global COVID-19 Diagnostics Market, by Test Type
8. Global COVID-19 Diagnostics Market, by Mode
9. COVID-19 Diagnostics Market Assessment by End Use
10. COVID-19 Diagnostics Market Assessment by Geography
11. Competitive Landscape
12. Company Profiles
- Cepheid
- 1drop Inc.
- ALDATU BIOSCIENCES
- Altona Diagnostics GmbH
- Perkin Elmer Inc.
- bioMerieux SA
- Danaher
- Hologic Inc.
- Abbott
- Luminex Corporation
- ADT Biotech
- Mylab Discovery Solutions Pvt Ltd.
- Laboratory Corporation of America Holdings
- Quest Diagnostics
- Quidel
- Neuberg Diagnostics
- Thermo Fisher Scientific Inc.
- F. Hoffman-La Roche Ltd.
- Veredus Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/9mszfv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.